ALV 317 (Nevirapine extended release 400 mg)
Pill imprint ALV 317 has been identified as Nevirapine extended release 400 mg.
Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- ALV 317
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NNRTIs
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Alvogen Inc.
More about nevirapine
Consumer resources
- Other brands: Viramune, Viramune XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
